Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production - PubMed (original) (raw)

Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production

A Desai-Mehta et al. J Clin Invest. 1996.

Abstract

We investigated the role of the costimulatory molecules, CD40 and its ligand CD40L, in the pathogenesis of human SLE. In comparison to normal subjects or patients in remission, PBMC from active lupus patients had a 21-fold increase in the frequency of CD40L-expressing, CD4+T cells. However, the expression of CD40L induced in either lupus or normal T cells by mitogenic stimulation could be down-regulated equally well by CD40 molecules on autologous B cells. Active lupus patients also had a 22-fold increase in percentage of CD8+ T cells expressing CD40L, consistent with their unusual helper activity in SLE. Surprisingly, patients with active lupus had a 20.5-fold increase in B cells that spontaneously expressed high levels of CD40L, as strongly as their T cells. Although lupus patients in remission had low levels of CD40L+ cells in the range of normal subjects, mitogen-induced upregulation of CD40L expression in the T and B cells was markedly greater than normal, suggesting an intrinsic defect. A mAb to CD40L blocked significantly the ability of lymphocytes from lupus patients with active and established disease to produce the pathogenic variety of antinuclear autoantibodies in vitro, bolstering the possibility of anti-CD40L immunotherapy for lupus. Future studies on the hyperexpression of CD40L could elucidate a regulatory defect in the pathogenic T and B cells of lupus.

PubMed Disclaimer

Cited by

Regulatory T cell (Treg) subsets return in patients with refractory lupus following stem cell transplantation, and TGF-beta-producing CD8+ Treg cells are associated with immunological remission of lupus.
Zhang L, Bertucci AM, Ramsey-Goldman R, Burt RK, Datta SK. Zhang L, et al. J Immunol. 2009 Nov 15;183(10):6346-58. doi: 10.4049/jimmunol.0901773. Epub 2009 Oct 19. J Immunol. 2009. PMID: 19841178 Free PMC article.
The soluble CD40 ligand sCD154 in systemic lupus erythematosus.
Kato K, Santana-Sahagún E, Rassenti LZ, Weisman MH, Tamura N, Kobayashi S, Hashimoto H, Kipps TJ. Kato K, et al. J Clin Invest. 1999 Oct;104(7):947-55. doi: 10.1172/JCI7014. J Clin Invest. 1999. PMID: 10510335 Free PMC article.
T cells in the pathogenesis of systemic lupus erythematosus: potential roles of CD154-CD40 interactions and costimulatory molecules.
Yellin MJ, Thienel U. Yellin MJ, et al. Curr Rheumatol Rep. 2000 Feb;2(1):24-31. doi: 10.1007/s11926-996-0065-8. Curr Rheumatol Rep. 2000. PMID: 11123036 Review.
Calcineurin in development and disease.
Chen L, Song M, Yao C. Chen L, et al. Genes Dis. 2021 Mar 15;9(4):915-927. doi: 10.1016/j.gendis.2021.03.002. eCollection 2022 Jul. Genes Dis. 2021. PMID: 35685477 Free PMC article. Review.
When the balance is broken: X-linked gene dosage from two X chromosomes and female-biased autoimmunity.
Syrett CM, Anguera MC. Syrett CM, et al. J Leukoc Biol. 2019 Oct;106(4):919-932. doi: 10.1002/JLB.6RI0319-094R. Epub 2019 May 24. J Leukoc Biol. 2019. PMID: 31125996 Free PMC article. Review.

References

1. J Immunol. 1995 Jun 15;154(12):6624-33 - PubMed
1. J Exp Med. 1995 Jun 1;181(6):2017-27 - PubMed
1. Immunity. 1995 Jun;2(6):645-53 - PubMed
1. J Immunol. 1995 Aug 15;155(4):2258-68 - PubMed
1. J Immunol. 1995 Aug 15;155(4):2269-81 - PubMed

Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production - PubMed (original) (raw)